< Back to companies
AIwell (aiwell)

AIwell (aiwell)

Tokyo, Japan

AIwell (aiwell) has developed a comprehensive digital imaging platform for proteins contained in specimens of humans, livestock, and pets, microanalysis of specimens, and mutual comparison of large amounts of image data. Early detection of biomarker candidates by observing protein mutations. It is also possible to obtain evidence of the efficacy of drug discovery. With the mission of "eliminating pre-existing illness from all over the world and making people healthier," AI-based diagnosis support, drug discovery support, and remote medical treatment support are possible when there are no subjective symptoms of the disease or before it becomes serious.

Only accessible to MedStartr community members. Join now

Company Info

Founded
2018
Website
www.aiwelljapan.com/

Categories

Precision Medicine/DiagnosticsPrevention

Disease Areas

Technologies

Digital PathologyMedical Imaging AIProteomicsBiomarker Analysis
Only accessible to MedStartr community members. Join now

What do you think of AIwell (aiwell)?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Innovation

Clinical Benefit

Feasibility

Scalability

Only accessible to MedStartr community members. Join now